Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment

Jose Higinio Dopeso; Silvia Mateo-Lozano; Elena Elez; Stefania Landolfi; Francisco Javier Ramos Pascual; Javier Hernández-Losa; Rocco Mazzolini; Paulo Rodrigues; Sarah Bazzocco; Maria Josep Carreras; Eloy Espín; Manel Armengol; Andrew Wilson; John Mariadason; Santiago Ramon; null Cajal; Josep Tabernero; Simo Schwartz Jr; Diego Arango

doi:10.1158/1078-0432.CCR-09-3275

Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment

Jose Higinio Dopeso, Silvia Mateo-Lozano, Elena Elez, Stefania Landolfi, Francisco Javier Ramos Pascual, Javier Hernández-Losa, Rocco Mazzolini, Paulo Rodrigues, Sarah Bazzocco, Maria Josep Carreras, Eloy Espín, Manel Armengol, Andrew Wilson, John Mariadason, Santiago Ramon, Cajal, Josep Tabernero, Simo Schwartz Jr, Diego Arango

Research output: Contribution to journal › Article › Research

31 Citations (Scopus)

Original language	English
Pages (from-to)	2375-2382
Journal	Clinical Cancer Research
Volume	16
Issue number	8
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-3275
Publication status	Published - 1 Apr 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-09-3275

Cite this

Dopeso, J. H., Mateo-Lozano, S., Elez, E., Landolfi, S., Pascual, F. J. R., Hernández-Losa, J., Mazzolini, R., Rodrigues, P., Bazzocco, S., Carreras, M. J., Espín, E., Armengol, M., Wilson, A., Mariadason, J., Ramon, S., Cajal, Tabernero, J., Jr, S. S., & Arango, D. (2010). Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment. Clinical Cancer Research, 16(8), 2375-2382. https://doi.org/10.1158/1078-0432.CCR-09-3275

Dopeso, Jose Higinio ; Mateo-Lozano, Silvia ; Elez, Elena ; Landolfi, Stefania ; Pascual, Francisco Javier Ramos ; Hernández-Losa, Javier ; Mazzolini, Rocco ; Rodrigues, Paulo ; Bazzocco, Sarah ; Carreras, Maria Josep ; Espín, Eloy ; Armengol, Manel ; Wilson, Andrew ; Mariadason, John ; Ramon, Santiago ; Cajal ; Tabernero, Josep ; Jr, Simo Schwartz ; Arango, Diego. / Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment. In: Clinical Cancer Research. 2010 ; Vol. 16, No. 8. pp. 2375-2382.

@article{1e02bd5225cb457fa255cdde49de592e,

title = "Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment",

author = "Dopeso, {Jose Higinio} and Silvia Mateo-Lozano and Elena Elez and Stefania Landolfi and Pascual, {Francisco Javier Ramos} and Javier Hern{\'a}ndez-Losa and Rocco Mazzolini and Paulo Rodrigues and Sarah Bazzocco and Carreras, {Maria Josep} and Eloy Esp{\'i}n and Manel Armengol and Andrew Wilson and John Mariadason and Santiago Ramon and Cajal and Josep Tabernero and Jr, {Simo Schwartz} and Diego Arango",

year = "2010",

month = apr,

day = "1",

doi = "10.1158/1078-0432.CCR-09-3275",

language = "English",

volume = "16",

pages = "2375--2382",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

Dopeso, JH, Mateo-Lozano, S, Elez, E, Landolfi, S, Pascual, FJR, Hernández-Losa, J, Mazzolini, R, Rodrigues, P, Bazzocco, S, Carreras, MJ, Espín, E, Armengol, M, Wilson, A, Mariadason, J, Ramon, S, Cajal, Tabernero, J, Jr, SS & Arango, D 2010, 'Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment', Clinical Cancer Research, vol. 16, no. 8, pp. 2375-2382. https://doi.org/10.1158/1078-0432.CCR-09-3275

Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment. / Dopeso, Jose Higinio; Mateo-Lozano, Silvia; Elez, Elena; Landolfi, Stefania; Pascual, Francisco Javier Ramos; Hernández-Losa, Javier; Mazzolini, Rocco; Rodrigues, Paulo; Bazzocco, Sarah; Carreras, Maria Josep; Espín, Eloy; Armengol, Manel; Wilson, Andrew; Mariadason, John; Ramon, Santiago; Cajal; Tabernero, Josep; Jr, Simo Schwartz; Arango, Diego.

In: Clinical Cancer Research, Vol. 16, No. 8, 01.04.2010, p. 2375-2382.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - Aprataxin tumor level predict response of colorectal cancer patients to irinotecan based treatment

AU - Dopeso, Jose Higinio

AU - Mateo-Lozano, Silvia

AU - Elez, Elena

AU - Landolfi, Stefania

AU - Pascual, Francisco Javier Ramos

AU - Hernández-Losa, Javier

AU - Mazzolini, Rocco

AU - Rodrigues, Paulo

AU - Bazzocco, Sarah

AU - Carreras, Maria Josep

AU - Espín, Eloy

AU - Armengol, Manel

AU - Wilson, Andrew

AU - Mariadason, John

AU - Ramon, Santiago

AU - Cajal, null

AU - Tabernero, Josep

AU - Jr, Simo Schwartz

AU - Arango, Diego

PY - 2010/4/1

Y1 - 2010/4/1

U2 - 10.1158/1078-0432.CCR-09-3275

DO - 10.1158/1078-0432.CCR-09-3275

M3 - Article

VL - 16

SP - 2375

EP - 2382

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -